Herbal therapy: a new pathway for the treatment of Alzheimer's disease

被引:0
|
作者
Jinzhou Tian
Jing Shi
Xuekai Zhang
Yongyan Wang
机构
[1] Beijing University of Chinese Medicine,BUCM Neurology Centre, Dongzhimen Hospital
[2] Hubei University of Chinese Medicine,Department of Preclinical Medicine
[3] The University of Manchester,Clinical Neuroscience Research Group
[4] Hope Hospital,Institute of Clinical Medicine
[5] China Academy of Chinese Medical Sciences,undefined
关键词
Mild Cognitive Impairment; Memantine; Clinical Dementia Rate; Aniracetam; Ginkgo Biloba Extract;
D O I
暂无
中图分类号
学科分类号
摘要
It has been a clinical challenge to treat Alzheimer's disease (AD). In the present commentary we discuss whether herbal therapy could be a novel treatment method for AD on the basis of results from clinical trials, and discuss the implications for potential therapy for AD pathophysiology. There is evidence to suggest that single herbs or herbal formulations may offer certain complementary cognitive benefits to the approved drugs. The current evidence supporting their use alone, however, is inconclusive or inadequate owing to many methodological limitations. Herbal mixtures may have advantages with multiple target regulation compared with the single-target antagonist in the view of traditional Chinese medicine. Several clinical trials using herbal mixtures are being conducted in China and will hopefully show promising results for treating AD in the near future.
引用
收藏
相关论文
共 50 条
  • [41] New therapeutic targets in the neurovascular pathway in Alzheimer's disease
    Zlokovic, Berislav V.
    NEUROTHERAPEUTICS, 2008, 5 (03) : 409 - 414
  • [42] New therapeutic targets in the neurovascular pathway in Alzheimer’s disease
    Berislav V. Zlokovic
    Neurotherapeutics, 2008, 5 : 409 - 414
  • [43] New hope for the diagnosis and therapy of Alzheimer's disease
    Kastenholz, Bernd
    PROTEIN AND PEPTIDE LETTERS, 2007, 14 (04): : 389 - 393
  • [44] Filling the void for new Alzheimer's disease therapy
    不详
    NATURE AGING, 2021, 1 (07): : 567 - 568
  • [45] Filling the void for new Alzheimer’s disease therapy
    Nature Aging, 2021, 1 : 567 - 568
  • [46] The olfactory system in Alzheimer's disease: Pathology, pathophysiology and pathway for therapy
    Kovacs, Tibor
    TRANSLATIONAL NEUROSCIENCE, 2013, 4 (01) : 34 - 45
  • [47] Pharmacological effects of herbal ingredients of Manasamitra vatakam in the treatment of Alzheimer's disease: A review
    Nair, Anju C.
    Kuriakose, Beena Briget
    Biju, Aswini
    Surendran, Sarika
    Sudheesh, M. S.
    Lakshmi, P. K.
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2025, 16 (01)
  • [48] Molecular evaluation of herbal compounds as potent inhibitors of acetylcholinesterase for the treatment of Alzheimer's disease
    Chen, Yan-Xiu
    Li, Guan-Zeng
    Zhang, Bin
    Xia, Zhang-Yong
    Zhang, Mei
    MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 446 - 452
  • [49] MicroRNAs as a New Target for Alzheimer's Disease Treatment
    Shademan, Behrouz
    Avci, Cigir Biray
    Karamad, Vahidreza
    Sogutlu, Fatma
    Nourazarian, Alireza
    MICRORNA, 2023, 12 (01) : 3 - 12
  • [50] New insights into huperzine A for the treatment of Alzheimer's disease
    Zhang, Hai-yan
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (09) : 1170 - 1175